Eli Lilly’s (LLY) weight-loss medications may have benefits for people suffering from Alzheimer’s disease, according to new studies. Take advantage of TipRanks Premium at 55% off! Unlock powerful ...
Eli Lilly said it received marketing authorization from the European Commission for Kisunla, a treatment for early symptomatic Alzheimer's disease. Kisunla showed in a phase 3 trial that it can ...
Pharmaceutical Technology on MSN
Healthcare burden of neurological conditions “growing”, WHO warns
The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen strong treatment advancements.
Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...
Eli Lilly continues to establish its dominance in the growing market for GLP-1 therapies. The company's oral candidate for diabetes treatment and weight loss looks very promising. Even after soaring ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback